These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1837713)

  • 1. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.
    Jauhiainen M; Koskinen P; Ehnholm C; Frick MH; Mänttäri M; Manninen V; Huttunen JK
    Atherosclerosis; 1991 Jul; 89(1):59-67. PubMed ID: 1837713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins and coronary heart disease in the Helsinki Heart Study.
    Mänttäri M; Huttunen JK; Koskinen P; Manninen V; Tenkanen L; Heinonen OP; Frick MH
    Eur Heart J; 1990 Dec; 11 Suppl H():26-31. PubMed ID: 2073911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
    von Eckardstein A; Schulte H; Cullen P; Assmann G
    J Am Coll Cardiol; 2001 Feb; 37(2):434-9. PubMed ID: 11216959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.
    Huttunen JK; Frick MH; Heinonen OP; Heinsalmi P; Manninen V; Mänttäri M; Romo M
    Drugs; 1988; 36 Suppl 3():32-6. PubMed ID: 3076118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.
    Koskinen P; Mänttäri M; Manninen V; Huttunen JK; Heinonen OP; Frick MH
    Diabetes Care; 1992 Jul; 15(7):820-5. PubMed ID: 1516498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty.
    Desmarais RL; Sarembock IJ; Ayers CR; Vernon SM; Powers ER; Gimple LW
    Circulation; 1995 Mar; 91(5):1403-9. PubMed ID: 7867180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.
    Cho JH; Lee DY; Lee ES; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Int J Cardiol; 2016 Nov; 222():233-237. PubMed ID: 27497100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
    Dahlen GH; Guyton JR; Attar M; Farmer JA; Kautz JA; Gotto AM
    Circulation; 1986 Oct; 74(4):758-65. PubMed ID: 2944670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.